![Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d68ee9929e10967b7bbaaa1abccfde11475c6f2d/3-Table1-1.png)
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar
![FRI0250 “ARE MYOSITIS ANTIBODIES SPECIFIC FOR IDIOPATHIC INFLAMMATORY MYOPATHY DIAGNOSIS?” CLINICAL CORRELATION OF A COHORT OF PATIENTS POSITIVE FOR MYOSITIS ANTIBODIES | Annals of the Rheumatic Diseases FRI0250 “ARE MYOSITIS ANTIBODIES SPECIFIC FOR IDIOPATHIC INFLAMMATORY MYOPATHY DIAGNOSIS?” CLINICAL CORRELATION OF A COHORT OF PATIENTS POSITIVE FOR MYOSITIS ANTIBODIES | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/Suppl_1/709.2/F1.large.jpg)
FRI0250 “ARE MYOSITIS ANTIBODIES SPECIFIC FOR IDIOPATHIC INFLAMMATORY MYOPATHY DIAGNOSIS?” CLINICAL CORRELATION OF A COHORT OF PATIENTS POSITIVE FOR MYOSITIS ANTIBODIES | Annals of the Rheumatic Diseases
![John Libbey Eurotext - European Journal of Dermatology - Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis John Libbey Eurotext - European Journal of Dermatology - Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis](https://www.jle.com/e-docs/00/04/D5/15/jleejd3750gr1.jpg)
John Libbey Eurotext - European Journal of Dermatology - Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis
![Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d68ee9929e10967b7bbaaa1abccfde11475c6f2d/6-Table2-1.png)
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis | Semantic Scholar
![Cureus | Antinuclear Antibody (ANA) and Anti-Mi-2-Alpha Positive Dermatomyositis Hinting a Cancer Diagnosis | Article Cureus | Antinuclear Antibody (ANA) and Anti-Mi-2-Alpha Positive Dermatomyositis Hinting a Cancer Diagnosis | Article](https://assets.cureus.com/uploads/figure/file/318796/lightbox_dfc715e07c7f11ec95f09527f96d1f90-dm.900line.png)